Trademark: 88655933
Word
CANCERNEXT-IVD
Status
Dead
Status Code
606
Status Date
Monday, November 28, 2022
Serial Number
88655933
Mark Type
4000
Filing Date
Tuesday, October 15, 2019
Published for Opposition
Tuesday, March 3, 2020
Abandoned Date
Monday, November 28, 2022

Trademark Owner History
AMBRY GENETICS CORPORATION - Owner At Publication

Classifications
44 Medical screening; Medical testing services for diagnostic or treatment purposes; DNA screening for medical purposes
CANCER NEXT-IVD

Trademark Events
Nov 28, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 28, 2022
Abandonment - No Use Statement Filed
Apr 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 31, 2022
Sou Extension 4 Granted
Mar 31, 2022
Sou Extension 4 Filed
Mar 31, 2022
Teas Extension Received
Oct 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2021
Sou Extension 3 Granted
Oct 26, 2021
Sou Extension 3 Filed
Oct 26, 2021
Teas Extension Received
Apr 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2021
Sou Extension 2 Granted
Apr 28, 2021
Sou Extension 2 Filed
Apr 28, 2021
Teas Extension Received
Oct 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2020
Sou Extension 1 Granted
Oct 28, 2020
Sou Extension 1 Filed
Oct 28, 2020
Teas Extension Received
May 5, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 5, 2020
Teas Change Of Correspondence Received
May 5, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 5, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 5, 2020
Teas Change Of Owner Address Received
Apr 28, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 3, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 3, 2020
Published For Opposition
Feb 12, 2020
Notification Of Notice Of Publication E-Mailed
Jan 24, 2020
Approved For Pub - Principal Register
Jan 21, 2020
Assigned To Examiner
Oct 19, 2019
New Application Office Supplied Data Entered In Tram
Oct 18, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24